Patent · US Active

Antibodies against human angiopoietin 2

US9073986B2 · kind B2 · utility

0Cited by

3References

6Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Ulrich Brinkmann · Weilheim, DE
Remko Albert Griep · Slemmestad, NO
Klaus Kaluza · Bad Heilbrunn, DE
Anita Kavlie · Oslo, NO
Christian Klein · Iffeldorf, DE
Joerg Thomas Regula · Munich, DE
Werner Scheuer · Penzberg, DE

Key dates

Filing date	Feb 6, 2013
Grant date	Jul 7, 2015
Priority date	—
Expiry date	Apr 8, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to antibodies against human Angiopoietin 2 (anti-ANG-2 antibodies), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.